About 40 generic companies enters ‘Twynsta’ market

Generics of ‘Twynsta(telmisartan, amlodipine),’ a leading drug in the hypertension complex market, are getting ready to be released.

As Twynsta lost the exclusivity with the expiration of the PMS(post-marketing surveillance) on the 18^th of August, pharmaceutical companies getting ready to launch its generics have been busy.

According to the Ministry of Food and Drug Safety(MFDS) on the 4^th, t...